Concepedia

Alan Hutchison

AH

Statistics

Publications

21

Citations

919

H-Index

18

Active since

1978

Affiliations

Novartis (Switzerland)(Current)

Wren Laboratories (United States)

Repligen (United States)

Alan Hutchison is an author at Novartis (Switzerland) specializing in pharmacology, medicinal chemistry, and medicine.

Publications per year

1978–2010

21

Publications

21

Characterization of the binding of [<sup>3</sup>H]‐CGS 19755: a novel N‐methyl‐<scp>d</scp>‐aspartate antagonist with nanomolar affinity in rat brain

Deborah E. Murphy, Alan Hutchison, Steven D. Hurt et al. · British Journal of Pharmacology · 1988 · 163 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

2-(Arylalkylamino)adenosin-5'-uronamides: a new class of highly selective adenosine A2 receptor ligands

Alan Hutchison, Michael Williams, Reynalda de Jesus et al. · Journal of Medicinal Chemistry · 1990 · 120 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Stereospecific total synthesis of dl-austamide

Alan Hutchison, Yoshito Kishi · Journal of the American Chemical Society · 1979 · 80 citations

Natural Sciences, Chemistry, Analytical Chemistry +6

4-(Phosphonoalkyl)- and 4-(phosphonoalkenyl)-2-piperidinecarboxylic acids: synthesis, activity at N-methyl-D-aspartic acid receptors and anticonvulsant activity

Alan Hutchison, Michael Williams, Christof Angst et al. · Journal of Medicinal Chemistry · 1989 · 79 citations

Medicine, Neuroscience, Pharmacology +17

2-Phenyl-4(5)-[[4-(pyrimidin-2- yl)piperazin-1-yl]methyl]imidazole. A Highly Selective Antagonist at Cloned Human D<sub>4</sub> Receptors

Andrew Thurkauf, Jun Yuan, Xi Chen et al. · Journal of Medicinal Chemistry · 1997 · 58 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +7

1–5 of 21